South Korea Again Delays Review of Tobacco Act Amendment; Synthetic Nicotine Still in a Regulatory Gap

Sep.11.2025
South Korea Again Delays Review of Tobacco Act Amendment; Synthetic Nicotine Still in a Regulatory Gap
On September 9, South Korea’s National Assembly again postponed reviewing amendments to the Tobacco Business Act that would classify synthetic nicotine as tobacco, prolonging a regulatory gap that leaves such products untaxed and legally sold near schools and via vending machines. This delay persists despite 36 of 38 OECD countries regulating synthetic nicotine at tobacco-equivalent standards and a November 2024 government study indicating substantial harms. The subcommittee plans to reconvene S

Key Points

 

  • Agenda squeeze: The Strategy & Finance Committee’s Subcommittee on Economy and Finance prioritized the Act on the Management of Public Institutions; the Tobacco Business Act (TBA) amendment was listed around Item 54 and was not taken up.
  • Regulatory vacuum: Because synthetic nicotine is not defined as “tobacco” under current law, it is untaxed and can be sold near schools and via vending machines, effectively serving as a “starter cigarette” for students.
  • International contrast: 36 of 38 OECD countries regulate synthetic nicotine at standards equivalent to conventional tobacco; countries without such rules often do not allow e-cigarette sales at all.
  • Legislative timeline: Talks began in 2016 but have not passed the Assembly. A November 2024 Ministry of Health and Welfare study found substantial harms from synthetic nicotine, raising hopes for progress, yet the February 2025 session also stalled.
  • What’s next: The subcommittee has progressed to agenda items immediately preceding the TBA amendments and plans to reconvene on September 16. Industry groups urge making the TBA amendment a top priority.

 


 

2Firsts, September 11, 2025 — The National Assembly’s Strategy and Finance Committee Subcommittee on Economy and Finance failed to review amendments to the Tobacco Business Act (TBA) on September 9 due to agenda conflicts, leaving synthetic nicotine unregulated once again, according to news.naver. The meeting prioritized deliberations on revisions to the Act on the Management of Public Institutions, and the TBA amendment—intended to bring synthetic nicotine under the legal definition of “tobacco”—was pushed down the agenda and ultimately not discussed before adjournment.

 

Under current law, synthetic nicotine is not classified as tobacco, meaning it is not subject to tobacco taxes and faces no location-based sales restrictions. As a result, products can legally be sold near school grounds and through vending machines. Owing to lower prices and easy access, synthetic-nicotine e-cigarettes are widely described as an entry product for students.

 

Although policy discussions began in 2016, the amendment has yet to clear the legislature. Expectations for faster progress rose after a November 2024 Ministry of Health and Welfare study concluded that synthetic nicotine carries significant risks; nevertheless, action stalled again during the February 2025 extraordinary session.

 

The subcommittee has advanced through the agenda up to the items just before the TBA amendments and plans to resume on September 16. Industry stakeholders expressed disappointment that the amendment was not debated and called for swiftly reconvening the subcommittee and placing the TBA revision at the top of the docket.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Several European sports outlets have reported on a suspected nicotine pouch seen in French footballer Michael Olise’s locker photo, bringing football’s long-running “snus” culture back into public view and highlighting brand visibility, product classification and public-health debate around nicotine pouches in sports settings.
News
Jun.25 by 2Firsts Perspectives
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
According to China Customs export data analyzed by 2Firsts, the United States remained China’s largest destination for vape-related exports during January-May 2026 despite a 13.82% year-on-year decline in export value. Meanwhile, exports to Japan, Russia, Indonesia and the United Arab Emirates recorded strong growth, highlighting continued diversification across China’s export markets.
Special Report
Jun.29
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy’s Competition and Market Authority (AGCM) has fined Philip Morris Italia €7 million, finding that the company’s use of “smoke-free future” and related claims in promoting products such as IQOS, VEEV and ZYN could mislead consumers.
Jun.16